TITLE

COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma

AUTHOR(S)
Song, Shumei; Guha, Sushovan; Kaifeng Liu; Buttar, Navtej S.; Bresalier, Robert S.
PUB. DATE
November 2007
SOURCE
Gut;Nov2007, Vol. 56 Issue 11, p1512
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Bile reflux contributes to oesophageal injury and neoplasia. COX-2 is involved in both inflammation and carcinogenesis; however, the precise mechanisms by which bile acids promote COX-2 expression in the oesophagus are largely unknown. We analysed the molecular mechanisms that govern bile acid-mediated expression of COX-2 in Barrett's oesophagus and oesophageal adenocarcinoma (OA). Design: The effects of bile acids on COX-2 expression were analysed in immortalised Barrett's oesophagus and OA cells using immunoblotting and transient transfections. Pharmacological inhibitors, phospho-specific antibodies, dominant-negative mutants and siRNA techniques were used to identify relevant signalling pathways. Flow cytometry and reactive oxygen species (ROS) scavengers were used to examine ROS involvement. Immunohistochemistry was performed on oesophageal mucosa obtained from an established rat model of bile reflux. Results: Unconjugated bile acids potently stimulated COX-2 expression and induced AKT and ERK1/2 phosphorylation in concert with COX-2 induction. These findings were mimicked in the in vivo rat model. Dominant-negative (DN) AKT and LY294002 (P13K inhibitor) or U0126 (MEK-1/2 inhibitor) blocked chenodeoxycholic acid (CD) and deoxycholic acid (DC) mediated COX-2 induction. CD and DC also induced CREB phosphorylation and AP-1 activity. CREB-specific siRNA and DN AP-1 blocked CD and DC-induced COX-2 induction. Finally, CD and DC increased intracellular ROS, while ROS scavengers blocked COX-2 induction and the signalling pathways involved. Conclusions: Unconjugated bile acids induce CREB and AP-1-dependent COX-2 expression in Barrett's oesophagus and OA through ROS-mediated activation of P13K/AKT and ERK1/2. This study enhances our understanding of the molecular mechanisms by which bile acids promote the development of oesophageal adenocarcinoma.
ACCESSION #
27560495

 

Related Articles

  • ELEVATED EXPRESSION OF CYCLOOXYGENASE-2 IN ADENOCARCINOMA OF THE PAROTID GLAND: INSIGHTS INTO MALIGNANT TRANSFORMATION OF PLEOMORPHIC ADENOMA. Sakamoto, Takashi; Kondo, Kenji; Sugasawa, Masashi; Yamasoba, Tatsuya; Kaga, Kimitaka // Annals of Otology, Rhinology & Laryngology;Nov2004, Vol. 113 Issue 11, p930 

    Pleomorphic adenoma, the most common type of tumor of the parotid gland, may transform into a malignant tumor. In the current study, we investigated whether the expression of cyclooxygenase-2 COX-2) is elevated in adenocarcinoma as compared to pleomorphic adenoma. Ten pleomorphic adenomas and 10...

  • Testing for Colon Neoplasia Susceptibility Variants at the Human COX2 Locus. Wiesner, Georgia L.; Platzer, Petra; Buxbaum, Sarah; Lewis, Susan; MacMillen, Mellissa; Olechnowicz, Joseph; Willis, Joseph; Chakravarti, Aravinda; Elston, Robert C.; Markowitz, Sanford D. // JNCI: Journal of the National Cancer Institute;04/18/2001, Vol. 93 Issue 8, p635 

    Examines whether the human cyclooxygenase 2 (COX2) locus may be linked to colon neoplasia in humans. Use of affected sibling-pair method to test for linkage of the human COX2 locus to colon neoplasia; Evaluation of COX2 susceptibility alleles in subpopulations of sibships with colon neoplasia.

  • ABSTRACTS FOR GASTROENTEROLOGISTS. Brown, J. Edward; Susinno, A. M.; Eisenstadt, H. B.; Cane, Walter; Yasuna, Alvin D.; Schwartz, Saul A.; Brenner, A. J.; McMahon, John M.; Ficarra, Bernard J.; Bernstein, Abraham; Morganstein, Louis K.; Deutsch, Irvin; DePrizio, Carl J.; Rost, Glenn S.; Joseph, Hans J.; Ledbetter, Paul; Gilbert, Samuel M.; Einsel, I. Henry; Immerman, Samuel L.; Epstein, Ezra J. // American Journal of Gastroenterology;Oct1964, Vol. 42 Issue 4, p460 

    Presents several abstracts of studies on gastroenterology. "Tumor-Forming Gastritis," by J. C. Hawksley; "Spontaneous Laceration and Rupture of Esophagus and Stomach," by Michael S. Bruno, W. Robson, N. Grier and William B. Ober; "Primary Lymphoid Neoplasms of the Stomach," by H. A. Ellis and...

  • Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Tselepis, C.; Morris, C.D.; Wakelin, D.; Hardy, R.; Perry, I.; Luong, Q.T.; Harper, E.; Harrison, R.; Attwood, S.E.A.; Jankowski, J.A.Z. // Gut;Feb2003, Vol. 52 Issue 2, p174 

    Background and aims: C-myc over expression is implicated in malignancy although to date this has not been studied in Barrett's metaplosia. We sought to determine c-myc expression in the malignant progression of Barrett's metaplasia and whether it may be induced by bile acids seen in...

  • The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. Peulen, Olivier; Gonzalez, Arnaud; Peixoto, Paul; Turtoi, Andrei; Mottet, Denis; Delvenne, Philippe; Castronovo, Vincent // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer death worldwide, with no satisfactory treatment to date. In this study, we tested whether the combined inhibition of cyclooxygenase-2 (COX-2) and class I histone deacetylase (HDAC) may results in a better control of...

  • COX-2 EXPRESSION IS AN INDICATOR OF POOR SURVIVAL IN PATIENTS UNDERGOING RESECTION FOR OESOPHAGEAL ADENOCARCINOMA. Bhandon, P.; Stacey, B.; Bateman, A.C.; Patel, P. // Gut;Apr2003 Supplement 1, Vol. 52, pA47 

    Introduction: The clinical relevance of cox-2 overexpression in oesophageal adenocarcinoma is uncertain. Aim: To test the hypothesis that cox-2 overexpression in oesophageal adenocarcinoma is associated with decreased patient survival. Methods: Oesophageal resection specimens were obtained from...

  • Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Yoshida, Seiya; Ujiki, Michael; Ding, Xian-Zhong; Pelham, Carolyn; Talamonti, Mark S.; Bell Jr, Richard H.; Denham, Woody; Adrian, Thomas E. // Molecular Cancer;2005, Vol. 4, p27 

    Background: Cyclooxygenase 2 (COX-2), the inducible form of prostaglandin G/H synthase, is associated with several human cancers including pancreatic adenocarcinoma. Pancreatic stellate cells (PSCs) play a central role in the intense desmoplasia that surrounds pancreatic adenocarcinoma. The...

  • GASTRIN INDUCES CYCLOOXYGENASE (COX)-2 EXPRESSION IN BARRETT'S OESOPHAGUS. Abdalla, A.; Sirieix, P. S.; Sanderson, I. R.; Fitzgerald, R. C. // Gut;Apr2004 Supplement 3, Vol. 53, pA58 

    The cyclooxygenase (COX)-2 enzyme is induced in inflammation and cancer. Furthermore, it is expressed in Barren's epithelium (BE) and associated adenocarcinoma (AC). However, there ore no previous longitudinal studies that examined COX-2 expression in the progression of BE to cancer....

  • Upregulation of cyclooxygenase-2 is associated with activation of the alternative nuclear factor kappa B signaling pathway in colonic adenocarcinoma. Guang Shi; Dong Li; Jinling Fu; Yan Sun; Yarong Li; Rongfeng Qu; Xin Jin; Dongfu Li // American Journal of Translational Research;2015, Vol. 7 Issue 9, p1612 

    Cyclooxygenase-2 expression by malignant tumors, including colonic adenocarcinoma, is associated with increased tumor aggression and poor prognosis. Nuclear factor kappa B is a key regulator of cyclooxygenase-2 and is regulated by two pathways, the 'canonical' and the 'alternative' pathway. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics